chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in upper back, neck, hands, knees shoulders. started having tingling and chills to body and chest pain 6 days after vaccination. Was seen in ED, EKG was negative. Motrin 800mg, baclofen 10mg rx were given. Still having arthralgias, but slightly improved.
light sensitivity; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (light sensitivity) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHOTOPHOBIA (light sensitivity). At the time of the report, PHOTOPHOBIA (light sensitivity) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
received the second dose 4 years after the first; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 4 years before 2nd dose of shingrix).   On 06-JUN-2023, the patient received the 2nd dose of Shingrix. On 06-JUN-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: received the second dose 4 years after the first). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 09-JUN-2023 The veterinarian called in to ask if their spouse had to restart their dosing schedule. They provided partial information about vaccine, event and patient. They also inquired about the recommendations of Shingrix in patients with prior episodes of shingles. The reporter consented to follow up. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
A few days after receiving the vaccine in my right arm I started having pain from the shoulder all the way to my fingers lifting my arm completely up would cause the pain to stop. No amount of pressure could be put on the right arm, or the pain would come. 3 months later and the same pain continues but with less frequency.
Patient was received a COVID vaccination and during her 15 minute waiting period, patient told pharmacist that she wanted the EMS called because she was having severe heart palpitations. Patient's BP was checked by 2nd pharmacist and the reading was 168/86/122. EMS was called to check out the patient. Patient's vitals were taken by EMS and subsequently released. Patient left the pharmacy area about 30 minutes following the incident stating that she felt better.
Temperature 101.4, headache, both arms and legs aching- father called 11/21/2008
Received the first dosage of Pfizer's vaccine and two days later I was rushed to the hospital and was diagnosed with acute appendicitis and had to receive an immediate appendectomy.
debilitating hip and leg pain within a day or two of vaccination - continues still today.  He was prescribed Celebrex , prednisone, acetaminophen w/codeine.  Has some relief but days where joint pain and hip pain especially impacts his ability to move arouns
My daughter was given the wrong Vaccine. She received the moderana not the Pitzer.  The first shot  Not sure what to do????Please advise. She has no side effects so far.
little soft pain at the place vaccine pushed; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jul-2021 and was forwarded to the company on 27-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little soft pain at the place vaccine pushed) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (little soft pain at the place vaccine pushed). At the time of the report, VACCINATION SITE PAIN (little soft pain at the place vaccine pushed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment details were reported.
The whole arm from the neck down to the Elbow it's painful can't sit up for long periods of time have pain patches on I do have I do have a rotator cuff issue but it wasn't it was bad but not as bad as right now since I got the shot I cannot hold my arm up without being in pain I can't sleep at night without having to put a patch on and that last shortly
KINRIX given Right arm on 10/6/09. Pt. mother called on 10/8/09 stating there is a red warm area size of mothers hand at site and pt. c/o itch there no fever or other Sx's. Mother instructed to use otc BENADRYL and anti-inflammatory like IBUPROFEN. on 10/12/09 mother states area is better.
PCR confirmed Monkeypox; Case reference number US-BN-2022-004667, is a spontaneous case report initially received from a healthcare professional (reference number: USBAV22-1943) on 11-Nov-2022 and concerns a patient of unknown gender or age.  The patient medical history was not provided.   The patient's concomitant medication was not provided.  On an unspecified date, the patient was negative to human immunodeficiency virus (HIV).  On unspecified date, the patient was vaccinated with the first dose of Jynneos (Smallpox and Monkeypox Vaccine, Live, Nonreplicating, batch number: unknown), at unknown dose, route of administration and anatomical location, for indication reported as to decrease the incidence of monkeypox.  On unspecified date, an unspecified amount of time after the first Jynneos dose, the patient was vaccinated with the second dose of Jynneos (batch number: unknown), at unknown dose, route of administration and unknown anatomical location.  On unspecified date, reported as one week after second Jynneos vaccination, a polymerase chain reaction (PCR) test confirmed the patient had monkeypox.   At the time of this report, outcome of event monkeypox was unknown.  The reporter assessed the event monkeypox as non-serious and as possibly related to Jynneos vaccination.   Additional information received from the physician on 11-Nov-2022: New information included seriousness and causality assessment for event monkeypox.  Additional information received from Bavarian Nordic on 14-Nov-2022 included the case ID.  This case is linked with US-BN-2022-004662, US-BN-2022-004663, US-BN-2022-004664, US-BN-2022-004665, US-BN-2022-004666, US-BN-2022-004668, US-BN-2022-004669 (same reporter).; Reporter's Comments: A patient of unknown demographics received the first and second doses of Jynneos, applied on unknown dates for monkeypox prevention. Reportedly, a week after the second dose, the patient developed the serious (medically significant) event of monkeypox, confirmed via PCR test. Monkeypox is unlisted for Jynneos. Medical history was not specified. Patient was negative for HIV. Concomitant medications were unknown. Considering that Jynneos is a non-replicating vaccine which does not contain the monkeypox, the event is assessed as not related to Jynneos. According to the insert for MVA-BN, vaccination with the product may not result in protection in all cases.; Sender's Comments: A patient of unknown demographics received the first and second doses of Jynneos, applied on unknown dates for monkeypox prevention. Reportedly, a week after the second dose, the patient developed the serious (medically significant) event of monkeypox, confirmed via PCR test. Monkeypox is unlisted for Jynneos. Medical history was not specified. Patient was negative for HIV. Concomitant medications were unknown. Considering that the full protection may not have been reached after 1 week after the second dose, this case is considered not related to vaccine.
Pt in 30 min waiting area.  At  10:36 am reported tongue feeling funny. Upon assessment tongue was thick , interfering with speech.  BP: 186/93,  Heart Rate : 66, Oxygen Saturation 99%, Temperature 97.6 F. Epinephrine 0.3 mL administered on left thigh at 10:42 am and  911 called. Pt reported inability to swallow and chest tightening at 10:51 am. Ambulance arrived.
Information has been received from a health professional concerning a patient (28 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F). It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day. Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the standards of the agency and was released. Additional information has been requested.
REPORTS FEVER, CHILLS, HEADACHE, SORE THROAT, AND VOMITING
Initial information received on 06-Feb-2019 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 5 weeks old male patient who received vaccines MENACTRA instead of HEPATITIS B VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 06-Feb-2019, the patient received a 0.5 mL dose of suspect MENACTRA lot U5833AA via unknown route in the thigh NOS. It was a case of actual medication error due to wrong vaccine administered and Inappropriate age at vaccine administration. It was unknown if any adverse event was occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
This spontaneous report was received from a nurse and refers to a 11-year-old female patient. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. On 18-OCT-2010, the patient was vaccinated with the first dose of GARDASIL (dose, route of administration, anatomical location, lot# and expiration date were not reported). On 11-FEB-2011, the patient was vaccinated with the second dose of GARDASIL (dose, route of administration, anatomical location, lot# and expiration date were not reported). The reporter stated that the patient received the third dose of GARDASIL too soon, on 29-APR-2011 (dose, route of administration, anatomical location, lot# and expiration date were not reported). The patient did not report or demonstrate any adverse events. Additional information has been requested.
First symptom was over-sensitive muscles (an achy "Don't touch me" feeling started around 7:30. Fever started around 11:30 pm and has continued into this morning.
2 days p/flu shot, lethargic & chilled; 72 hrs later had cough & flu for 2 wks;
after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch; When scratching the itchiness it bleeds; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch) and SKIN HAEMORRHAGE (When scratching the itchiness it bleeds) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy, Asthma, Blood pressure abnormal (UNSPECIFIED ALLERGIES), Chronic fatigue syndrome, Anxiety, Fibromyalgia, Depression, Knee pain and Itchy rash (prescribed Thimerosal Cream, like a cortisone cream on 17-Feb-2021) since February 2021. Concomitant products included DESVENLAFAXINE SUCCINATE (PRISTIQ) for Antidepressant drug clearance NOS, CLONAZEPAM (KLONOPIN) for Anxiety, MONTELUKAST SODIUM (SINGULAIR) for Asthma, PROPRANOLOL for Blood pressure management, THIMEROSAL from 17-Feb-2021 to an unknown date for Itchy rash, SILODOSIN and PARACETAMOL (TYLENOL) for Knee pain, ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CONDITION AGGRAVATED (after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch) and SKIN HAEMORRHAGE (When scratching the itchiness it bleeds). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; HYDROCORTISONE at a dose of 1 dosage form and KETOCONAZOLE at a dose of 1 dosage form. At the time of the report, CONDITION AGGRAVATED (after first shot this seemed to get worse, it was itching more and more and turned into a rash, like it bleeds a little when you scratch) and SKIN HAEMORRHAGE (When scratching the itchiness it bleeds) had not resolved.            The reporter did not specify if additional treatment began (with Benadryl, Hydrocortisone cream, and Ketoconazole shampoo) before or after the second dose administration of mRNA-1273.   This case was linked to MOD-2021-075575.
Facial numbness and tingling that lasted for several hours. Also right hand numbness. I would like to know if this is an allergic reaction and precludes the second dose?
From 11-03-2017 until 11-05-2017 dizziness, nausea, headache, swollen warm, hard, red patch on arm just below injection site.
general feeling of not feeling well; headache; temperature; feeling sick to the stomach; she went to get the pneumonia vaccine, but was given a second Fluzone High dose vaccine; she accidentally gave her another FluzoneHD instead of a pneumonia shot; Initial information received on 22-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves female patient who experienced general feeling of not feeling well (Feeling unwell), headache(Headache), temperature(fever), feeling sick to the stomach(Pain stomach), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received second dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number and Expiry date unknown) via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious general feeling of not feeling well (Feeling unwell),headache(Headache),feeling sick to the stomach (Pain stomach),temperature (fever) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It is also a case of Wrong vaccine administered, and Extra dose administered.  It was reported that given a second fluzone high dose vaccineand she accidentally gave her another fluzone hd instead of a pneumonia shot.  (Other relevant tests included no lab data).  Final diagnosis was feeling sick to the stomach, temperature, headache and general feeling of not feeling well.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for all the events  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number is requested.
INJECTION SITE FELT ITCHY; ENTIRE BODY FLUSH; BODY SWEATY; FELT ROUGH; NAUSEATED; HEADACHE; HIGH FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced injection site felt itchy, entire body flush, body sweaty, felt rough, nauseated, headache, and high fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and high fever, and the outcome of injection site felt itchy, entire body flush, nauseated, felt rough and body sweaty was not reported. This report was non-serious.
itchy and red again and this lasted for 5 days.; itchy and red again and this lasted for 5 days.; bad headache, bad neck, and stuffy nose.; bad headache, bad neck, and stuffy nose.; bad headache, bad neck, and stuffy nose.; arm became red and itchy and that lasted for 5 days.; arm became red and itchy and that lasted for 5 days.; arm became pink and itchy.; arm became pink and itchy.; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (arm became pink and itchy.), PRURITUS (arm became pink and itchy.), ERYTHEMA (arm became red and itchy and that lasted for 5 days.), NECK PAIN (bad headache, bad neck, and stuffy nose.) and NASAL CONGESTION (bad headache, bad neck, and stuffy nose.) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced SKIN DISCOLOURATION (arm became pink and itchy.) and PRURITUS (arm became pink and itchy.). On 09-Feb-2021, the patient experienced ERYTHEMA (arm became red and itchy and that lasted for 5 days.) and PRURITUS (arm became red and itchy and that lasted for 5 days.). On 11-Feb-2021, the patient experienced NECK PAIN (bad headache, bad neck, and stuffy nose.), NASAL CONGESTION (bad headache, bad neck, and stuffy nose.) and HEADACHE (bad headache, bad neck, and stuffy nose.). On 18-Feb-2021, the patient experienced PRURITUS (itchy and red again and this lasted for 5 days.) and ERYTHEMA (itchy and red again and this lasted for 5 days.). On 13-Feb-2021, SKIN DISCOLOURATION (arm became pink and itchy.), PRURITUS (arm became pink and itchy.), ERYTHEMA (arm became red and itchy and that lasted for 5 days.) and PRURITUS (arm became red and itchy and that lasted for 5 days.) had resolved. On 23-Feb-2021, PRURITUS (itchy and red again and this lasted for 5 days.) and ERYTHEMA (itchy and red again and this lasted for 5 days.) had resolved. At the time of the report, NECK PAIN (bad headache, bad neck, and stuffy nose.), NASAL CONGESTION (bad headache, bad neck, and stuffy nose.) and HEADACHE (bad headache, bad neck, and stuffy nose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       In between her two episodes of itchy red arm, she was fine for five days.  No concomitant medications were reported. No treatment medication was reported.
Swelling, pain, warmth, and tightness started in left leg the same night I had the second dose of vaccine. Approximately 10 hours after second dose
only recieved two of the doses /in 2007; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (received 1st dose in 2007) and Twinrix (received 2nd dose in 2007).   On an unknown date, the patient received the 3rd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: Age at vaccination was not reported. The patient recieved only two doses of the Twinrix back  in 2007, which led to incomplete course of vaccination. The patient asked how effective could they be and how long did they last. The patient took a hepatitis test at the physicians office. No further information reported. The reporter did not consented to follow up.
30 minutes after vaccination patient reported that she felt lightheaded, "foggy", chest tightness, nausea, blurred vision.   States she felt like she was going to pass out.   Had about 3 episodes of this about 5 min. apart..   Patient states she has vasopressor syndrome however the last episode was one year ago.  Vitals:   132/90 P:  72    2nd B/P   124/80.    Patient also reports that she did not eat since evening before (no breakfast).    Monitored patient for approximately half hour and patient was escorted by husband to location in facilty where she could lay down & rest.  Husband present.  Public staff left patient w/husband at facility due to patient reporting she was feeling somewhat better.  Location also had physicians on site.       Public Health staff then called patient at 12:30 pm for update:  Pt reports still having some "episodes" lightheaded.  States facility did EKG w/normal result.  States she will follow-up w/her cardiologist.         5:45 PM   Phone call to patient who states she is doing somewhat better but states when she got up to put dishes away she felt winded, lightheaded and had some chest tightness.   States her head feels "clearer".
Oral Thrush symptoms ( mouth blisters, redness,stinging) began 3/5/21, worsened over the next few days, was diagnosed by urgent care doctor on 3/7/21.